Blackstone Inc’s Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share VHAQ.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-400,000
Closed -$87K 372
2021
Q4
$87K Hold
400,000
﹤0.01% 463
2021
Q3
$100K Hold
400,000
﹤0.01% 535
2021
Q2
$141K Hold
400,000
﹤0.01% 533
2021
Q1
$152K Buy
+400,000
New +$214K ﹤0.01% 431

Other funds holding VHAQ.WS

Blackstone Inc's VHAQ.WS Position: Q1 2022 in Review

Blackstone Inc sold out of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) in Q1 2022, closing a stake of 400,000 shares — an estimated $87K sold.

Blackstone Inc first reported a position in VHAQ.WS in Q1 2021 and held it in 4 quarters. The position peaked at $152K in Q1 2021. 32 funds tracked by Wall St. Rank hold VHAQ.WS as of Q1 2022.

  • Blackstone Inc reported no remaining Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position as of Q1 2022 after selling out during the quarter.
  • Blackstone Inc sold 400,000 Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share shares in Q1 2022, an estimated $87K.
  • Blackstone Inc first reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in Q1 2021 and held it in 4 quarters.
  • Blackstone Inc's Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position peaked at $152K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share as of Q1 2022.

Based on Blackstone Inc's 13F filing for Q1 2022, filed 16 May 2022.